Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?

Glioblastoma (GBM) is an aggressive and fatal malignancy that despite decades of trials has limited therapeutic options. Antibody drug conjugates (ADCs) are composed of a monoclonal antibody which specifically recognizes a cellular surface antigen linked to a cytotoxic payload. ADCs have demonstrate...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sagun Parakh, Joseph Nicolazzo, Andrew M Scott, Hui Kong Gan
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/75bd5259ae494948a7493d5c5e2d644f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!